Concepedia

Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer

Kang‐Seo Park, Hyun‐Kyoung Kim, Jung-Hwa Lee, Yong‐Bock Choi∥, Seong‐Yeol Park∥, Sei‐Hoon Yang, Soo‐Youl Kim, Kyeong‐Man Hong

Journal of Cancer Research and Clinical Oncology · 2009 · 107 citations · 32 references

DOIFull text

Open access

Concepts

References

32

Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

Joan H. Schiller, David Harrington, Chandra P. Belani et al. · New England Journal of Medicine · 2002 · 4.9K citations

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi et al. · Science · 2007 · 4.4K citations

COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER

J Oan H. S Chiller, D Avid H Arrington, C Handra P. B Elani et al. · 2002 · 3.7K citations

, , +13

Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB"

Sankar Ghosh, David Baltimore · Nature · 1990 · 1.2K citations

, , +11

Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life

M.H. Cullen, Lucinda Billingham, C.M. Woodroffe et al. · Journal of Clinical Oncology · 1999 · 448 citations